For patients seeking effective, evidence-based weight management options currently available in the UK, the following licensed treatments may be appropriate depending on individual clinical circumstances: Semaglutide (Wegovy): Licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities, subject to NICE criteria (NICE TA875) Tirzepatide (Mounjaro): Licensed in the UK for type 2 diabetes
It is advisable to check with your insurer and the treatment provider regarding coverage and safety standards
Regardless of the dosage, your practitioner will recommend weekly injections for several weeks, maybe even months until you reach your desired goal
Diabetes 45 , 91100 (1996)
It may be used in experimental designs focused on metabolic biology, incretin signaling, or related pathways
EASY TO APPLY - Peel the patch from its backing and place it on clean, dry skin with minimal hair